Patent Assignment
Reel/Frame 054734/0650
Assignment of Assignor's Interest
Recorded: 2020-12-22
Pages: 3
Assignee
GENENTECH, INC.
1 DNA WAY, SOUTH SAN FRANCISCO, CALIFORNIA, 94080-4990
Covered Properties
(2)
Combination Therapy of a Type Ii Anti-CD20 Antibody with a Selective Bcl-2 Inhibitor
Combination Therapy of a Type Ii Anti-CD20 Antibody with a Selective Bcl-2 Inhibitor
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 22, 2020
From: KLEIN, CHRISTIAN
To: ROCHE GLYCART AG
Reel/Frame 054734/0660 →
Assignment of Assignor's Interest
Dec 22, 2020
From: ROCHE GLYCART AG
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 054734/0670 →
Assignment of Assignor's Interest
Jan 15, 2021
From: F. HOFFMANN-LA ROCHE AG
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 054938/0587 →
Assignment of Assignor's Interest
Feb 2, 2021
From: GENENTECH, INC.
To: GENENTECH, INC.; ABBVIE INC.
Reel/Frame 055117/0984 →
Assignment of Assignor's Interest
Feb 3, 2021
From: ROBERTS, ANDREW W.; SEYMOUR, JOHN F.
To: ABBVIE INC.
Reel/Frame 055138/0411 →
Assignment of Assignor's Interest
Feb 5, 2021
From: HUMERICKHOUSE, ROD A.
To: ABBVIE INC.
Reel/Frame 055169/0208 →